Evidence map›Paper›PMID 34492061›Full record

ArticlePloS one2021

Evaluation of the long-term effect of polyhexamethylene guanidine phosphate in a rat lung model using conventional chest computed tomography with histopathologic analysis.

Cherry Kim, Sang Hoon Jeong, Jaeyoung Kim, Ja Young Kang, Yoon Jeong Nam, Ariunaa Togloom, Jaehyung Cha, Ki Yeol Lee, Chang Hyun Lee, Eun-Kee Park and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Drug delivery · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Cherry KimDepartment of Radiology, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.
Sang Hoon JeongMedical Science Research Center, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.
Jaeyoung KimMedical Science Research Center, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.
Ja Young KangMedical Science Research Center, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.
Yoon Jeong NamMedical Science Research Center, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.
Ariunaa TogloomMedical Science Research Center, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.
Jaehyung ChaMedical Science Research Center, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.
Ki Yeol LeeDepartment of Radiology, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.
Chang Hyun LeeDepartment of Radiology, College of Medicine, Seoul National University, Seoul National University Hospital, Seoul, South Korea.
Eun-Kee ParkDepartment of Medical Humanities and Social Medicine, College of Medicine, Kosin University, Busan, South Korea.
Ju-Han LeeDepartment of Pathology, Ansan Hospital, Korea University College of Medicine, Danwon-gu, Ansan-si, Gyeonggi, South Korea.ORCID 0000-0002-5929-5734
Korea University · KRKosin University · KRSeoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There have been no studies on the effects of polyhexamethylene guanidine phosphate (PHMG) after a long period of exposure in the rodent model. We aimed to evaluate long-term lung damage after PHMG exposure using conventional chest computed tomography (CT) and histopathologic analysis in a rat model. A PHMG solution was intratracheally administrated to 24 male rats. At 8, 26, and 52 weeks after PHMG instillation, conventional chest CT was performed in all rats and both lungs were extracted for histopathologic evaluation. At 52 weeks after PHMG instillation, four carcinomas had developed in three of the eight rats (37.5%). Bronchiolo-alveolar hyperplasia and adenoma were found in rats at 8, 26, and 52 weeks post-instillation. The number of bronchiolo-alveolar hyperplasia significantly increased over time (P-value for trend< 0.001). The severity of lung fibrosis and fibrosis scores significantly increased over time (P-values for trend = 0.002 and 0.023, respectively). Conventional chest CT analysis showed that bronchiectasis and linear density scores suggestive of fibrosis significantly increased over time (P-value for trend < 0.001). Our study revealed that one instillation of PHMG in a rat model resulted in lung carcinomas and progressive and irreversible fibrosis one year later based on conventional chest CT and histopathologic analysis. PHMG may be a lung carcinogen in the rat model.

Indexed as

AnimalsDisease Models, AnimalGuanidinesHumansLungLung DiseasesPulmonary FibrosisRatsThoraxTomography, X-Ray ComputedGuanidinespolyhexamethyleneguanidine

Identifiers

PMID34492061
PMCPMC8423271
OpenAlexW3198051368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.